We could not find any results for:
Make sure your spelling is correct or try broadening your search.
By Saabira Chaudhuri Covidien PLC (COV) is voluntarily recalling its Duet TRS staplers after receiving one report that links the tissue reinforcement material to a post-operative injury after...
CHICAGO, Feb. 11 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for EMC, UPS, NYT, A, and COV. Seven Summits Strategic Investments' PriceWatch Alerts are available at...
Covidien PLC (COV) said the Food and Drug Administration has approved its product to seal tissue tears that occur during spine surgery. Sales for spinal use of Duraseal, which is already approved...
By Jon Kamp Of DOW JONES NEWSWIRES A U.S. judge has denied an attempt by Covidien Ltd. (COV) to stop private drug maker URL Pharma Inc. from launching a low-dose generic version of Covidien's...
By Jon Kamp Of DOW JONES NEWSWIRES Big companies in the supply chain for medical-scanning isotopes advised customers this week of supply shortages linked to sidelined reactors that help make the...
DALLAS, June 16 /PRNewswire/ -- InvestorSoup.com announces the availability of stock alerts on leading, active stocks in today's news. Each stock alert highlights recent news, trading activity...
(Updates with S&P's decision to drop Covidien from indexes and after-hours stock quote, beginning in first paragraph.) By Jon Kamp Of DOW JONES NEWSWIRES Covidien Ltd. (COV) shareholders...
(Adds details on Standard & Poor's 500 index starting in eighth paragraph. Updates share price.) By Jon Kamp Of DOW JONES NEWSWIRES Covidien Ltd. (COV) shareholders have approved shifting the...
By Jon Kamp Of DOW JONES NEWSWIRES Covidien Ltd. (COV) shareholders have approved shifting the medical company's place of incorporation to Ireland from Bermuda, a move that could carry tax...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions